Victrex | VCT

Stock Price
718.00
Daily Change
9.00 1.27%
Monthly
4.51%
Yearly
-24.97%
Q3 Forecast
714.12

Peers Price Chg Day Year Date
Fujifilm 3,607.00 40.00 1.12% -4.60% Sep/05
Nitto Denko 3,459.00 99.00 2.95% 52.99% Sep/05
Albemarle 81.54 2.27 2.86% 5.99% Sep/05
Ecolab 273.56 -1.38 -0.50% 11.66% Sep/05
Givaudan 3,504.00 21.00 0.60% -20.53% Sep/05
Sika AG 185.40 1.25 0.68% -28.42% Sep/05
Symrise 82.32 0.98 1.20% -31.83% Sep/06
Victrex 718.00 9.00 1.27% -24.97% Sep/05


Victrex plc traded at 718.00 this Friday September 5th, increasing 9.00 or 1.27 percent since the previous trading session. Looking back, over the last four weeks, Victrex gained 4.51 percent. Over the last 12 months, its price fell by 24.97 percent. Looking ahead, we forecast Victrex plc to be priced at 714.12 by the end of this quarter and at 702.62 in one year, according to Trading Economics global macro models projections and analysts expectations.

Victrex plc is a United Kingdom-based holding company. The principal activity of the Company is the manufacture and sale of high-performance polymers. The Company develops solutions in polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based polymers and selects semi-finished and finished parts. The Company operates through two segments: Sustainable Solutions and Medical. The Sustainable Solutions segment focuses on its energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited and Juvora Limited.